LSI Industries (NASDAQ:LYTS – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued on Friday, Benzinga reports. They currently have a $30.00 price target on the construction company’s stock. HC Wainwright’s price target indicates a potential upside of 43.27% from the stock’s previous close. Several […]

HC Wainwright reissued their buy rating on shares of Plug Power (NASDAQ:PLUG – Free Report) in a research note published on Tuesday, Marketbeat Ratings reports. They currently have a $7.00 price objective on the electronics maker’s stock. A number of other research analysts also recently weighed in on the company. UBS Group reissued a “buy” […]

HC Wainwright reaffirmed their buy rating on shares of Americas Gold and Silver (NYSEAMERICAN:USAS – Free Report) in a research note published on Thursday morning,Benzinga reports. HC Wainwright currently has a $9.25 price objective on the stock. Separately, Zacks Research upgraded Americas Gold and Silver from a “strong sell” rating to a “hold” rating in […]

HC Wainwright reiterated their buy rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research report released on Wednesday, MarketBeat reports. HC Wainwright currently has a $20.00 target price on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on ENTA. Wall Street Zen cut shares […]

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They currently have a $358.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 19.40% from the […]

HC Wainwright reaffirmed their buy rating on shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) in a report issued on Friday morning,Benzinga reports. HC Wainwright currently has a $165.00 target price on the biotechnology company’s stock. Other equities analysts have also issued reports about the company. Wolfe Research lowered Corcept Therapeutics from a “peer perform” […]